• Home
  • About us
  • Team
    • Management team
    • Advisory Board
  • Portfolio companies
    • Exited investments
    • Current investments
  • News
  • Contact

Management team

Home / Team / Management team
Partner

Alexey Konov

  • MSU (1989); Ph.D., molecular biology, University Louis Pasteur, France (1998)
  • 20 years of overall experience in management and life sciences, including 8 years of venture investment experience ("Bioprocess Capital Ventures")
  • Board member at Retrosense Therapeutics, LLC (acquired by NYSE:AGN) and Bonti Inc. (acquired by NYSE:AGN)
Partner

Robert Karl

  • Fachhochschule München (1992)
  • Ex-Mallinckrodt Pharmaceuticals, commercial VP for Russia/CIS, Turkey, Middle East, Latin America (except Brazil), Australia and New Zealand
  • Over 20 years of work experience in the pharmaceutical industry, including executive roles at Schering Plough, MSD and Covidien AG
Senior Associate, Head of Analysis

Ivan Olovnikov

  • MSU (2007), Caltech (2010-2013), Ph.D., molecular biology (2013)
  • Over 10 years of work experience in life sciences and industry (Russia, USA, Australia).
  • Co-founder of a biotech startup. Author of 20 scientific publications
Investment director

Igor Gonikhin

  • LSE and Higher School of Economics (2008)
  • 10 years of experience in private equity (Da Vinci Capital) and corporate finance advisory (Deloitte & Touche)
  • Expertise in leading investment deals in financial, tech and IT sectors
Associate, Therapeutics

Sophia Zubanova

  • MSU Faculty of Chemistry (2014), PhD in Chemistry from MSU
  • 6 years of scientific experience in biochemistry and genetics
  • Engaged in analyzing biotechnological companies and market trends
Associate, Head of Bio-IT

Alexander Martynov

  • MSU Faculty of Bioengineering and Bioinformatics (2013), visiting PhD student at HMS and MIT, PhD from Skolkovo Institute of Technology
  • Founder of two start-ups (computational assessment of drugs, emotion recognition)
  • Engaged in the assessment of companies at the intersection of biotech and IT
  • Management team
  • Advisory Board

News

13
oct

Immusoft and Takeda Collaborate to Discover and Develop Cell Therapies for Rare Neurometabolic Disorders

More
25
jun

Pipeline Therapeutics Appoints Scott Oross as General Counsel

More
23
jun

Immusoft Announces Formation Of Scientific Advisory Board

More